CLVS (CLVS) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 118 253 sessions, December 20, 2021 to December 20, 2022
- Largest daily move
- -71.6% close of November 9, 2022
- 1-year change
- -97.5% closing prices, December 20, 2021 to December 20, 2022
- 5-year change
- -99.9% closing prices, December 20, 2017 to December 20, 2022
Company Description
CLVS (Nasdaq: CLVS) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $11.8M.
CLVS has declined 97.5% over the past year. The last closing price was $0.0812.
This page collects what Stock Titan holds for CLVS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CLVS (CLVS) closed at $0.0812 on December 20, 2022. Over the past 12 months, the price has lost 97.5%.
CLVS Metrics & Rankings
Price returns through December 20, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CLVS has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, earnings, conferences. View all CLVS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CLVS Company Profile & Sector Positioning
CLVS (CLVS) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing CLVS often look at related companies in the same sector, including XTL Biopharmaceuticals Ltd. American (XTLB), Soligenix, Inc. (SNGX), Leap Therapeutics, Inc. (LPTX), Sensei Biotherapeutics, Inc. (SNSE), and Moleculin Biotech, Inc. (MBRX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLVS's relative position within its industry.